Age, Neuropathology, and Dementia
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Research in Alzheimer's disease is focused mainly on younger old persons, whereas studies involving very old persons report attenuated relationships between the pathological features of Alzheimer's disease and dementia. METHODS: We assessed 456 brains donated to the population-based Medical Research Council Cognitive Function and Ageing Study from persons 69 to 103 years of age at death. We used a standard neuropathological protocol that included measures of the pathological features of Alzheimer's disease, cerebral atrophy, and cerebrovascular disease. Neuropathological variables were dichotomized to represent no burden or a mild burden of pathological lesions as compared with a moderate or severe burden. Logistic regression was used to estimate the effect of age on the relationship between neuropathological features and dementia. RESULTS: The difference in the prevalence of moderate and severe Alzheimer's-type pathological changes between persons with and those without dementia decreased with increasing age. The association between neocortical neuritic plaques and dementia was strong at 75 years of age (odds ratio, 8.63; 95% confidence interval [CI], 3.81 to 19.60) and reduced at 95 years of age (odds ratio, 2.48; 95% CI, 0.92 to 4.14), and similar attenuations with advancing age were observed in the association between other pathological changes related to Alzheimer's disease and dementia in all brain areas. In contrast, neocortical cerebral atrophy maintained a relationship with age in persons with dementia at both 75 years of age (odds ratio, 5.11; 95% CI, 1.94 to 13.46) and 95 years of age (odds ratio, 6.10; 95% CI, 2.80 to 13.28) and thus distinguished the cohort with dementia from the cohort without dementia. CONCLUSIONS: The association between the pathological features of Alzheimer's disease and dementia is stronger in younger old persons than in older old persons. Age must be taken into account when assessing the likely effect of interventions against dementia on the population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“loss of growth factors, such as the brain-derived neurotrophic factor,96 may contribute to the brain atrophy associated with Alzheimer disease and VCI.134,135”
In the citing paper
“The Baltimore Longitudinal Study of Aging (O’Brien, et al., 2009), the Honolulu-Asia Aging Study (White, 2009), and the MRC-CFAS (Savva, et al., 2009) have similarly reported dissociations between plaques, tangles or other pathological lesions and cognition.”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Savva, et al., 2009
In the citing paper
“Autopsy studies reveal at the time of death, brains from cognitively normal individuals frequently contain plaques [77, 234-237].”
From The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives (2014) · cites this paper as [235]
In the citing paper
“Frequently, however, alternative pathologies are also seen in demented patients with plaques and tangles [50–52].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [51]
In the citing paper
“Decades of clinical-pathological correlative studies, now corroborated by a decade of neuroimaging studies, also demonstrate a sizable percentage of the non-demented elderly have plaques [40, 51, 54, 55, 58–68].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [51]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336
MULTI-INFARCT DEMENTIA A CAUSE OF MENTAL DETERIORATION IN THE ELDERLY
HACHINSKI, V (1974) · The Lancet · doi:10.1016/s0140-6736(74)91496-2 · Cited by 1,093
Research works printed but not linked: 1
- Fratiglioni L, 2000, Neurology, 54, S10
Cited by
Items 701–800 of 920
Guerchet, M., & Prince, M. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804607-4.00012-5 · Cited by 3
Vascular Dementia and Cognitive Impairment
Seshadri, S. S., Caunca, M. R., & Rundek, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00018-1 · Cited by 3
Swiatek, V. M., Schreiber, S., Amini, A., Hasan, D. M., Rashidi, A., Stein, K., Neyazi, B., & Sandalcioglu, I. E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195864 · Cited by 4
Zeng, Y., Yang, H., Lai, Y., Bi, Y., Sun, C., Jiang, H., Liu, X., Xu, S., Li, Y., & Meng, J. (2025) · Neuroepidemiology · doi:10.1159/000545885 · Cited by 4
Gates, N. J., Karim, S., Rutjes, A. W., Ware, J., March, E. G., & Vernooij, R. W. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012279 · Cited by 7
Multiproteinopathy, neurodegeneration and old age: a case study
Rojas, J. C., Stephens, M. L., Rabinovici, G. D., Kramer, J. H., Miller, B. L., & Seeley, W. W. (2018) · Neurocase · doi:10.1080/13554794.2017.1420199 · Cited by 3
Neurochemical Aspects of Dementia
Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816347-4.00001-5 · Cited by 4
Dementia in old age: from diagnosis to fatal outcome
Mikhaylova, N. M., & Sokolova, O. N. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2020-3-64-72 · Cited by 3
Characteristics of Early-Onset Dementia in Chiba Prefecture, Japan: A Multicenter Survey
Hirano, S., Sakakibara, R., Komatsu, N., Shimizu, K., Ishikawa, M., Hosoi, N., Asahi, T., Shuno, T., Sugihara, H., Kanai, S., et al. (2021) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000518294 · Cited by 3
Neuropsychiatric Aspects of Vascular Cognitive Impairment
Poggesi, A., & Pantoni, L. (2013) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-1-4471-2428-3_11 · Cited by 3
Integrating Data for Modeling Biological Complexity
Hunter, S., & Brayne, C. (2013) · Springer eBooks · doi:10.1007/978-3-642-30574-0_52 · Cited by 3
Self-citationBae, Y., Kang, C., Choi, U., Jung, H., & Lee, S. W. (2025) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaf047 · Cited by 3
Hellquist, E., Janelidze, S., Weidung, B., Franzon, K., Giedraitis, V., Ingelsson, M., Bali, D., Veličkaitė, V., Zetterberg, H., Hansson, O., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251390387 · Cited by 2
Alzheimer Syndrome or Age-Related Dementia—History, Therapy and Prevention
Bermejo‐Pareja, F., & del Ser, T. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217752 · Cited by 2
Garcia, D., Sharma, S. R. R., Saito, N., Beckett, L. A., Sevilla, L. N. C., Vasquez, L. R., DeCarli, C. S., Gutman, D., Vizcarra, J. C., Coughlin, D. G., et al. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf152 · Cited by 2
Vascular dementia: why pathology is still important
Neal, J. (2011) · Reviews in Clinical Gerontology · doi:10.1017/s0959259811000207 · Cited by 2
Fitriana, L. A., Pragholapati, A., Rohaedi, S., Anggadiredja, K., Setiawan, I., & Adnyana, I. K. (2021) · Journal of Engineering Research · doi:10.36909/jer.asseee.16059 · Cited by 3
Décarie-Labbé, L., Dialahy, I. Z., Corriveau‐Lecavalier, N., Mellah, S., & Belleville, S. (2024) · Cortex · doi:10.1016/j.cortex.2024.01.011 · Cited by 2
Alzheimer’s Disease Prevention and Treatment Based on Population-Based Approaches
Perneczky, R. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3774-6_2 · Cited by 2
Blood biomarkers of Alzheimer’s disease: important considerations for use in clinical practice
Fullam, S., O’Dowd, S., & O’Connor, A. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-02017 · Cited by 2
Olfactory Testing and Gray Matter Volume: A Combined Approach to Predict the Conversion to Alzheimer
Casadio, C., Ballotta, D., Ricci, F., Zanelli, V., Carpentiero, O., Corni, M. G., Bardi, E., Filippini, N., Lui, F., Nichelli, P., et al. (2025) · Brain Sciences · doi:10.3390/brainsci15030310 · Cited by 2
Beta-amyloid toxicity increases with hydrophobicity in the presence of metal ions
Granzotto, A., Bolognin, S., Ščančar, J., Milačić, R., & Zatta, P. F. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1001-0_8 · Cited by 3
Bonavita, V., Caltagirone, C., Mariani, C. B., Padovani, A., Scarpini, E. A., & Sorbi, S. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129000 · Cited by 2
The Challenge and Public Health Implications of Alzheimer Overdiagnosis in the Oldest Old
Fotuhi, M. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.138 · Cited by 2
Memory Training and Task Specificity in 90-99-Year-Old Seniors with Mild Cognitive Impairment
Magaro, P. A., Brotter, B., & Jalees, M. (2015) · Advances in Aging Research · doi:10.4236/aar.2015.41001 · Cited by 2
Mohamed, R. E.-E.-D., Aboelsafa, A. A., & Abo-Sheisha, D. M. (2014) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1016/j.ejrnm.2014.01.005 · Cited by 2
An Alzheimer disease presenilin mutation, syndrome diversity, and a shrinking world
Swerdlow, R. H. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d3e429 · Cited by 2
Neuropathological Correlates of Falling in the CC75C Population-Based Sample of the Older Old
Richardson, K., Hunter, S., Dening, T., Xuereb, J. H., Matthews, F. E., Brayne, C., & Fleming, J. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322636 · Cited by 3
Self-citationCasolla, B., & Leys, D. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107239340.016 · Cited by 2
Population-Based Approaches to Alzheimer’s Disease Prevention
Perneczky, R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_2 · Cited by 2
Brainin, M., & Heiss, W. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107239340.010 · Cited by 2
Cerebral Multimorbidity in Aging
Jellinger, K. A. (2016) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2017/1.1001 · Cited by 2
Parting with the Concept of Alzheimer’s Disease in Senium
Kalvach, P., & Vogner, M. (2019) · OBM Geriatrics · doi:10.21926/obm.geriatr.1903060 · Cited by 2
Curing Alzheimer’s Disease: Myriad Causes and Myriad Cures Await
Garrett, M. D. (2019) · OBM Geriatrics · doi:10.21926/obm.geriatr.1903063 · Cited by 2
A Note on Changing Approach to Diagnosis of Alzheimer’s Disease
Tartaglione, A., & Sette, M. D. (2014) · EMJ Neurology · doi:10.33590/emjneurol/10310003 · Cited by 2
Robust Biomarkers: Methodologically Tracking Causal Processes in Alzheimer’s Measurement
Keyser, V., & Sarry, L. (2020) · Boston studies in the philosophy of science · doi:10.1007/978-3-030-29179-2_13 · Cited by 2
Target Tau, not Amyloid, to Prevent and Treat Alzheimer’s Disease
Esiri, M. M. (2020) · OBM Geriatrics · doi:10.21926/obm.geriatr.2001103 · Cited by 2
Amyloid in the ageing brain: New frameworks and perspectives
Hunter, S., & Brayne, C. (2021) · Aging Brain · doi:10.1016/j.nbas.2021.100008 · Cited by 2
Self-citationPsychopathology of Dementia: Psychology’s Pivotal Role
Garrett, M. D. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.5.1039 · Cited by 2
Salivary Chromogranin A: A Novel Diagnostic Bio-Marker for Alzheimer's Disease
Alagendran, S., Prabhu, S. V., Pushpa, N., Ponraj, M., Rajasekaran, M., Fernandez-Saavedra, G., & Archunan, G. (2022) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-2825 · Cited by 2
Functional Glial Activation Mediates Phenotypic Effects of APOEɛ4 and Sex in Alzheimer’s Disease
Lane, R. M., Li, D. X., & Darreh‐Shori, T. (2024) · Neuroglia · doi:10.3390/neuroglia5030022 · Cited by 2
Biomarkers and Risk Factors of Dementia
Schrijvers, E. M. C. (2011) · RePub (Erasmus University Rotterdam) · Cited by 3
Cerebral amyloid burden and Alzheimer's disease subtypes – does localization information matter?
Zetterberg, H., & Mattsson, N. (2015) · European Journal of Neurology · doi:10.1111/ene.12777 · Cited by 2
Unresolved Questions in Alzheimer's Research: Will Biomarkers Help?
Zetterberg, H. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.120 · Cited by 2
Strategies for Conditional Two-Locus Nonparametric Linkage Analysis
Ängquist, L. H., Hössjer, O., & Groop, L. (2008) · Human Heredity · doi:10.1159/000126049 · Cited by 2
Prostacyclin as a Negative Regulator of Angiogenesis in the NeurovasculaturePreprint
Womack, T., Li, J., Govyadinov, P. A., Mayerich, D. M., & Eriksen, J. L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.28.441854 · Cited by 2
Murphy, A. J., Williamson, J. B., & Lamb, D. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_691 · Cited by 2
Perani, D. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.8343973.8791070 · Cited by 2
Assessment of Alzheimer-related Pathologies of Dementia Using Machine Learning Feature SelectionPreprint
Rajab, M. A., Jammeh, E., Taketa, T., Brayne, C., Matthews, F. E., Su, L., Ince, P. G., Wharton, S. B., & Wang, D. Y. Q. (2022) · Research Square · doi:10.21203/rs.3.rs-1584607/v1 · Cited by 2
Self-citationMaschio, C., Wang, J., Maheshwari, U., Keller, A., Rominger, A., Konietzko, U., Nordberg, A. K., Höck, C., Nitsch, R. M., & Ni, R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.28.582443 · Cited by 3
Barros, A. G. D. A., Soares, T. O., Lage, A. F., Cintra, M. T. G., de Paula, J. J., Malheiro, O. B., Falcão, A. E., Nogueira, C. A. C., de Carvalho, L. B., Romano‐Silva, M. A., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1557016 · Cited by 1
Strużek, K., Karamus, K., Rejmak, R. W., Borowska-Łygan, M., Urban, W., Tomaszewski, J., Gryc, A., Lipiec, J., & Grudzień, M. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.80.60238 · Cited by 1
Jessup, M., Iglesias, N. J., Tadisina, K. K., Xu, K. Y., Mella, J. R., Pinchuk, L., Singh, D. P., Tse, D. T., Nayak, V. V., & Coelho, P. G. (2025) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2025.100117 · Cited by 1
Lighting and Sleep Quality in the Elderly: A Systematic Review to Inform Future Research Design
Zhou, F., Göçer, Ö., & Hu, W. (2025) · Buildings · doi:10.3390/buildings15173142 · Cited by 3
Bagenda, C. N., Mudondo, H., Ssemwanga, E., Nzaramba, D., Ssedyabane, F., Ojuko, S., Musinguzi, B., Akiteng, W., Agaba, B. B., Osuwat, L. O., et al. (2025) · SAGE Open Medicine · doi:10.1177/20503121251374391 · Cited by 1
Jorge, L., Canário, N., Martins, R., Abrunhosa, A., Santana, I. J., & Castelo-Branco, M. S. (2025) · Neuroimage Reports · doi:10.1016/j.ynirp.2025.100305 · Cited by 2
Innovation in Alzheimer’s disease needs more than pharmaceutical solutions
Brayne, C., & Richard, E. (2026) · BMJ · doi:10.1136/bmj.s788 · Cited by 1
Self-citationIdiotypic-susceptible Alzheimer’s disease: a clinically relevant, neurofibrillary tangle subtype
Robinson, J. L., Cai, H., Loh, N., Vazquez, O., Khodakaramimaghsoud, Z., Suh, E. R., Deerlin, V. M. V., Yushkevich, P. A., Mechanic-Hamilton, D. J., Xie, S. X., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03013-6 · Cited by 2
Mundo, S. R. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1938670 · Cited by 1
Biological Basis for Cerebral Dysfunction in Schizophrenia in Contrast with Alzheimer’s Disease
Kuljiš, R. O., Colom, L. V., & Rojo, L. E. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00119 · Cited by 1
Concomitant pathologies II: Neurodegenerative conditions
Kovács, G. G., Ferrer, I., & Alafuzoff, I. I. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.018 · Cited by 2
Lin, Z. S., Avinash, G. B., McMillan, K. M., Yan, L., & Minoshima, S. (2014) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2043060 · Cited by 1
Möglichkeiten moderner Bildgebungstechnologien im Rahmen der Frühdiagnostik von Alzheimererkrankung
Unschuld, P. G. (2015) · Therapeutische Umschau · doi:10.1024/0040-5930/a000674 · Cited by 1
Advances in Alzheimer’s Disease Management
Gauthier, S. G., & Rosa‐Neto, P. (2012) · doi:10.2217/9781780840840 · Cited by 1
Vascular Dementia and Vascular Cognitive Decline
Seshadri, S. S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10017-x · Cited by 1
Advanced epidemiologic and analytical methods
Albanese, E. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00003-3 · Cited by 2
Lu, C., Dun, L., Liu, G., Lei, X., Wei, B., An, H., Zhou, Z., Wu, Y., & Zeng, J. (2016) · Cited by 1
Redox Based-Peripheral Biomarkers in Alzheimer’s Disease: Challenges, Limits and Prospects
Perrotte, M., Pincemail, J., Haddad, M., & Ramassamy, C. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_19 · Cited by 2
Neltner, J. H., & Nelson, P. T. (2017) · Wiley eBooks · doi:10.1002/9781118661895.ch1 · Cited by 2
Kim, J. H., Lim, H., Lee, J.-U., Cho, J. H., Kim, G. S., Choi, S. H., Lee, J. H., & Initiative, A. D. N. (2017) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2017.16.4.114 · Cited by 1
Mild Cognitive Impairment: Diagnosis and Treatment
Nina-Estrella, R. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-95360-1_26 · Cited by 2
Unraveling the syndrome of age-associated diseases: Common pathways and novel therapeutic strategies
Mertelsmann, R. H., Faletti, L. E., & Zirlik, K. (2019) · Journal of Science Humanities and Arts - JOSHA · doi:10.17160/josha.6.2.539 · Cited by 1
Insulin resistance and Alzheimer’s disease
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00006-7 · Cited by 1
Bhargava, S., Jain, I., Singh, M., & Rachana, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_18 · Cited by 1
Zou, W. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_4 · Cited by 1
Is Simpler Always Better? The Case for Going Beyond the Amyloid Hypothesis in Alzheimer’s Disease
Bocti, C. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240488 · Cited by 1
How Attribution Theory Helps to Explain Psychiatric Nosology
Garrett, M. D. (2024) · American Journal of Health Research · doi:10.11648/j.ajhr.20241204.13 · Cited by 1
Britton, M. K., Hoogerwoerd, H., Juhasz, J., Johnson, K. J., Stewart, P. D., Bharadwaj, P. K., Merritt, S. S., Jessup, C. J., Wright, C. B., Hishaw, G. A., et al. (2025) · GeroScience · doi:10.1007/s11357-025-02027-4 · Cited by 1
Kinoshita, D. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2012.tde-26092012-140403 · Cited by 2
Ancestralidade da população de São Paulo e correlação com alterações neuropatológicas no idoso
Schlesinger, D. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2010.tde-17122010-142628 · Cited by 4
Neuroinflammation in early and late onset Alzheimer´s disease: a multimodal analysis
Taipa, R. J. F. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Mistry, H. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Assessment of Alzheimer-related Pathologies of Dementia Using Machine Learning Feature SelectionPreprint
Rajab, M. A., Jammeh, E., Taketa, T., Brayne, C., Matthews, F. E., Su, L., Ince, P. G., Wharton, S. B., & Wang, D. Y. Q. (2022) · medRxiv · doi:10.1101/2022.04.28.22274107 · Cited by 1
Self-citationMurphy, A. J., Williamson, J. B., & Lamb, D. G. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_691-1 · Cited by 1
Tsang, G. (2022) · Cronfa (Swansea University) · doi:10.23889/suthesis.61814 · Cited by 2
Gregoire, S. M. (2014) · UCL Discovery (University College London) · Cited by 3
Health technology assessment of diagnostic strategies for Alzheimer’s disease
Handels, R. L. H. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140911rh · Cited by 1
Åslund, A. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2
Synapses, spines, zinc and pathology of Alzheimer's disease.
Familtsev, D. (2013) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/420 · Cited by 1
Järvinen, P. P. (2011) · Helda - University of Helsinki Institutional Repository
Schieb, H. (2011) · DuEPublico (University of Duisburg-Essen)
Age, rate of change in neuropathology, and trajectory of cognitive decline
Pillai, J. A. (2013) · Annals of Neurology · doi:10.1002/ana.24038
Richardson, E. E. (2011) · Human Biology
Glial cell reactivity in mouse models reflecting different aspects of Alzheimer's disease
Behrendt, M. G. (2012) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.14767
Balasa, M. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Diagnostic Tools: Fluid Biomarkers for Alzheimer’s Disease
Zetterberg, H., Hampel, H. J., & Blennow, K. (2012) · Advances in biological psychiatry · doi:10.1159/000335385
Ravona‐Springer, R., & Korczyn, A. D. (2011) · Clinical Investigation · doi:10.4155/cli.11.136
Biomarkers for neurological disorders – call for standardization
Torzewski, M. (2014) · Journal of Laboratory Medicine · doi:10.1515/labmed-2014-0002
Is AD a homogeneous nosologic entity? Yes
Martínez‐Martín, P. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1059-0
Metadata
- Authors
- Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C.
- Affiliations
- University of Cambridge (GB)
- University of Sheffield (GB)
- MRC Biostatistics Unit (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-05-28
- Volume
- 360
- Issue
- 22
- Pages
- 2302-2309
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1998088268
- Cited by
- 900
- References
- 34
- Citations by year
- 2026: 18 · 2025: 36 · 2024: 57 · 2023: 25 · 2022: 33 · 2021: 52 · 2020: 41 · 2019: 60 · 2018: 51 · 2017: 51 · 2016: 56 · 2015: 59 · 2014: 73 · 2013: 75 · 2012: 71
- FWCI
- 43.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, dementia, neuropathology, age effects, cerebrovascular disease, neuritic plaques, brain donation, MRC Cognitive Function and Ageing Study
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Aging, Alzheimer Disease, Atrophy, Autopsy, Brain, Cerebrovascular Disorders, Dementia, Female, Humans, Male, Odds Ratio, Lewy Bodies, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.